← Patent Expiry Watch
October 19, 2026 · Patent expires September 15, 2027
LYNKUET (ELINZANETANT): The 2027 Generic Opportunity Window
Core patent 7683056 for LYNKUET (ELINZANETANT) by Bayer Healthcare Pharmaceuticals Inc. expires on September 15, 2027. Zero generic (ANDA) approvals exist for this active ingredient as of October 19, 2026. No other future-expiring patents on this product are listed. (No real litigation signal found.)
What we do
We track expirations like this continuously
This is one drug, picked for today's post. A Portfolio Retainer watches an entire portfolio or compound class on an ongoing basis and flags new matching filings as they publish.